An antiretroviral drug used for the treatment of HIV infections.Raltegravir works by targeting integrase, an HIV enzyme. Raltegravir is first in a novel class of antiretroviral drugs known as integrase inhibitors and it was produced by Merck & Co.Reference standards of Raltegravir API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Raltegravir
Catalogue No.:PA 18 57000
CAS :
Molecular Formula : C20H21FN6O5
Molecular Weight : 444.42
N-(4-Fluorobenzyl)-5-methoxy-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide
Catalogue No.:PA 18 04510
Raltegravir β-D-Glucuronide
Catalogue No.:PA 18 04520
Molecular Formula : C26H29FN6O11
Molecular Weight : 620.54
Raltegravir β-D-Glucuronide Methyl Ester
Catalogue No.:PA 18 04530
Molecular Formula : C27H31FN6O11
Molecular Weight : 634.57
Raltegravir 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester
Catalogue No.:PA 18 04540
Molecular Formula : C33H37FN6O14
Molecular Weight : 760.68
5-Hydroxy-2-[1-methyl-1-[[benzylcarbamoyl]amino]ethyl]-6-methoxypyrimidine-4-carboxylic Acid Methyl Ester-d3
Catalogue No.:PA STI 050200
Molecular Formula : C18H18D3N3O6
Molecular Weight : 378.39
Raltegravir-d3 Potassium Salt
Catalogue No.:PA STI 077050
Molecular Formula : C20H17D3FKN6O5
Molecular Weight : 485.53
Raltegravir-D3
Catalogue No.:PA STI 077060
Molecular Formula : C20H18D3FN6O5
Molecular Weight : 447.44
Raltegravir-13C6 Potassium Salt
Catalogue No.:PA STI 077070
Molecular Formula : C1413C6H20FKN6O5
Molecular Weight : 488.46
Raltegravir-d3 β-D-Glucuronide
Catalogue No.:PA STI 077080
Molecular Formula : C26H26D3FN6O11
Molecular Weight : 623.56
Raltegravir β-D-Glucuronide Methyl Ester-d3
Catalogue No.:PA STI 077090
Molecular Formula : C27H28D3FN6O11
Molecular Weight : 637.59
Raltegravir 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester-d3
Catalogue No.:PA STI 077100
Molecular Formula : C33H34D3FN6O14
Molecular Weight : 763.7
2-(2-Aminopropan-2-yl)-4-((3-fluorobenzyl)carbamoyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-5-yl Pivalate
Catalogue No.:PA 18 04550
Molecular Formula : C21H27FN4O4
Molecular Weight : 418.47
4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(methylamino)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl Pivalate
Catalogue No.:PA 18 04560
Molecular Formula : C22H29FN4O4
Molecular Weight : 432.5
(Z)-N-(2-((2-(4-((4-Fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)amino)-2-oxoacetyl)acetohydrazonic Acid
Catalogue No.:PA 18 04580
Molecular Formula : C20H23FN6O6
Molecular Weight : 462.44
Deoxadiazole Oxalamide Raltegravir
Catalogue No.:PA 18 04590
Molecular Formula : C18H20FN5O5
Molecular Weight : 405.39
N-(2-(5-Hydroxy-4-((4-methoxybenzyl)carbamoyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
Catalogue No.:PA 18 04600
Molecular Formula : C21H24N6O6
Molecular Weight : 456.46
Ethyl 2-[[1-[4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]amino]-2-oxoacetate
Catalogue No.:PA 18 04610
Molecular Formula : C20H23FN4O6
Molecular Weight : 434.42
N-(2-(4-((4-Fluorobenzyl)carbamoyl)-5-hydroxy-6-methoxypyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
Catalogue No.:PA 18 04620
Ethyl N-(2-((2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)amino)-2-oxoacetyl)acetohydrazonate
Catalogue No.:PA 18 04630
Molecular Formula : C22H27FN6O6
Molecular Weight : 490.49
5-Methyl-1,3,4-oxadiazole-2-carboxylic Acid
Catalogue No.:PA 18 04570
Molecular Formula : C4H4N2O3
Molecular Weight : 128.09
2-Methyl-2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propanoic Acid
Catalogue No.:PA 18 04640
Molecular Formula : C8H11N3O4
Molecular Weight : 213.19
Raltegravir Mixture of G & F
Catalogue No.:PA 18 04650
Molecular Weight : 490.48
Raltegravir Oxidative Impurity
Catalogue No.:PA 18 0571000
Molecular Formula : C9H8FNO3
Molecular Weight : 197.17
Raltegravir 13CD3
Catalogue No.:PA STI 089016
Molecular Formula : C1913CH18D3FN6O5
Molecular Weight : 448.43
Methyl 2-((2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)amino)-2-oxoacetate
Catalogue No.:PA 18 0571001
Molecular Formula : C19H21FN4O6
Molecular Weight : 420.4
N-(1-Amino-2-methyl-1-oxopropan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide
Catalogue No.:PA 18 0571002
Molecular Formula : C8H12N4O3
Molecular Weight : 212.21
Methyl 2-(2-(((benzyloxy)carbonyl)amino)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate
Catalogue No.:PA 18 0571003
Molecular Formula : C17H19N3O6
Molecular Weight : 361.35
2-(4-((3-Fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl benzylcarbamate
Catalogue No.:PA 18 0571004
Molecular Formula : C24H25FN4O5
Molecular Weight : 468.49
Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate
Catalogue No.:PA 18 0571005
Molecular Formula : C23H23FN4O5
Molecular Weight : 454.46
4-((4-Fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-yl 5-methyl-1,3,4-oxadiazole-2-carboxylate
Catalogue No.:PA 18 0571006
Molecular Formula : C24H23FN8O7
Molecular Weight : 554.5
Benzyl (2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)carbamate
Catalogue No.:PA 18 0571007
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
